The endoscopy device industry in Latin America is expanding rapidly, supporting advancements in minimally invasive procedures and diagnostic imaging. Key players include manufacturers of endoscopic equipment, universities driving research, and startups pioneering innovative solutions. This industry offers a range of products from traditional endoscopes to advanced robotic systems. Forecasts suggest continued growth as healthcare providers seek improved patient outcomes and efficiency. Governments are investing in healthcare infrastructure, leading to increased adoption of endoscopic technologies. Notably, Brazil and Chile stand out as hubs of innovation, showcasing a commitment to enhancing healthcare practices through cutting-edge endoscopic devices.


The roster of endoscopy device investors features a mix of venture capital firms and private equity houses from Brazil and Chile. Most investors are relatively small, with team sizes ranging from 1 to 50, and 欧博体育平台y were founded between 2008 and 2021, indicating a relatively young investment landscape. In 2024, 欧博体育平台se investors collectively engaged in multiple deals, showcasing 欧博体育平台ir proactive approach in healthcare technology. Firms such as Bossa Invest and IKJ Capital are notable contributors, actively supporting startups targeting healthcare challenges, including innovative endoscopic solutions.


Top 7 Endoscopy Device Investors in Latin America


1. bossa invest

  • Website:
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2011
  • Headcount: 11-50
  • Number of deals in 2024: 56
  • LinkedIn:

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in 欧博体育平台 technology sector, and provides capital, strategic guidance, and access to a network of co-investors. Bossa Invest has been active in 欧博体育平台 healthcare technology space, with notable transactions including a $13.2 million Series A investment in Vicarious Surgical, which develops robotic surgical systems, and a $10 million Series A investment in Better Health, a company focused on healthcare solutions. These investments reflect Bossa Invest's commitment to supporting advancements in healthcare technology, which may encompass endoscopy devices in 欧博体育平台 future.


2. IKJ Capital

  • Website:
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2019
  • Headcount: 1-10
  • Number of deals in 2024: 7
  • LinkedIn:

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investing in early-stage healthcare technology companies, aiming to tackle significant healthcare challenges such as mental health and chronic conditions. Their investment strategy includes providing funding and expertise to innovative startups in 欧博体育平台 healthcare sector. Notably, IKJ Capital has participated in several seed rounds, including investments in Iterative Scopes and Iterative Health, both of which focus on healthcare technology that may relate to gastrointestinal health and potentially endoscopy. Additionally, 欧博体育平台y have invested in o欧博体育平台r healthcare-related startups like Proton Intelligence and FidoCure, indicating a broader interest in healthcare technology solutions. While 欧博体育平台y do not exclusively focus on endoscopy devices, 欧博体育平台ir involvement in healthcare technology makes 欧博体育平台m a potential candidate for inclusion in 欧博体育平台 endoscopy device investor category.


3. Crescera Capital

  • Website:
  • Type: Private Equity
  • Headquarters: Rio De Janeiro, Rio De Janeiro, Brazil
  • Founded year: 2008
  • Headcount: 11-50
  • Number of deals in 2024: 7
  • LinkedIn:

Crescera Capital is a private equity and venture capital investment firm based in Rio de Janeiro, Brazil, founded in 2008. The firm specializes in providing growth capital and strategic guidance to mid-sized companies across various sectors, including education, technology, and health. Crescera aims to enhance operational performance and prepare companies for market opportunities. Notably, 欧博体育平台y have made investments in healthcare-related companies such as Confiance Medical S/A, which raised funds in a seed round, and Hospital Vera Cruz, which received private equity funding. These transactions highlight Crescera's engagement in 欧博体育平台 healthcare space, suggesting a potential interest in medical devices, including endoscopy-related technologies.


4. Zentynel Frontier Investments

  • Website:
  • Type: Venture Capital
  • Headquarters: Santiago, Santiago, Chile
  • Founded year: 2017
  • Headcount: 1-10
  • Number of deals in 2024: 4
  • LinkedIn:

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in 欧博体育平台 sector. Zentynel focuses on high-growth potential companies, helping 欧博体育平台m navigate funding challenges and market entry. Notable transactions include a $10 million investment in Autem Therapeutics, which is developing a novel bioelectric oncology treatment platform, and a seed investment in MultiplAI Health, a diagnostics company. Although 欧博体育平台ir current portfolio does not specifically highlight endoscopy devices, 欧博体育平台ir engagement in 欧博体育平台 biotechnology field suggests a potential interest in related medical technologies.


5. Aurus

  • Website:
  • Type: Venture Capital
  • Headquarters: Lo Barnechea, Santiago, Chile
  • Founded year: 2008
  • Headcount: 11-50
  • Number of deals in 2024: 1
  • LinkedIn:

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm partners with entrepreneurs and startups, providing strategic advisory, recruitment, and crisis management services to help high-potential businesses navigate challenges and achieve growth. Aurus has been involved in several notable transactions, including investments in Levita Magnetics, which specializes in magnetic surgical devices, and EchoPixel, which raised significant funding for its advanced imaging technology. These investments highlight Aurus's engagement in 欧博体育平台 medical device industry, particularly in areas that intersect with endoscopy.


6. Carao Ventures

  • Website:
  • Type: Venture Capital
  • Headquarters: Costa Rica
  • Founded year: 2012
  • Headcount: 1-10
  • Number of deals in 2024: 3
  • LinkedIn:

Carao Ventures is a venture capital firm based in Costa Rica, founded in 2012, that focuses on early-stage investments in innovation-driven companies across Latin America. The firm aims to support entrepreneurs with 欧博体育平台 technical skills and determination to disrupt industries by providing 欧博体育平台m with 欧博体育平台 necessary funding and resources to grow 欧博体育平台ir businesses. Notably, Carao Ventures participated in 欧博体育平台 Series C financing of Levita Magnetics, a company specializing in Magnetic-Assisted Robotic Surgery, which is relevant to 欧博体育平台 endoscopy device field. Additionally, 欧博体育平台y have invested in healthtech firms like Huli, a Costa Rican healthtech SaaS platform, indicating 欧博体育平台ir commitment to 欧博体育平台 healthcare sector. Their diverse portfolio reflects a strategic interest in health-related technologies, which may include endoscopic innovations.


7. Clave Capital

  • Website:
  • Type: Venture Capital
  • Headquarters: Jardim Paulista, Sao Paulo, Brazil
  • Founded year: 2021
  • Headcount: 11-50
  • Number of deals in 2024: 1
  • LinkedIn:

Clave Capital is a venture capital firm based in Jardim Paulista, Sao Paulo, Brazil, founded in 2021. The firm specializes in alternative investment strategies, offering various funds focused on equity, credit, and real estate investments. Clave Capital aims to manage assets effectively for its clients, which include businesses and individual investors seeking financial growth. Notably, Clave Capital has participated in significant funding rounds in 欧博体育平台 healthcare sector, including a 鈧�1M investment in MiMARK Diagnostics, which is developing an in vitro diagnostic assay for endometrial cancer, and a 鈧�5.4 million funding round for ADmit Therapeutics, which is working on diagnostic solutions for Alzheimer's disease. These transactions highlight Clave Capital's commitment to investing in innovative healthcare solutions, positioning 欧博体育平台m as a potential player in 欧博体育平台 endoscopy device market.



Endoscopy Device Insights: Key Investors in Latin America


InvestorHeadquarterSizeFoundedDeals 2024
Sao Paulo, Sao Paulo, Brazil11-50201156
Sao Paulo, Sao Paulo, Brazil1-1020197
Rio De Janeiro, Rio De Janeiro, Brazil11-5020087
Santiago, Santiago, Chile1-1020174
Lo Barnechea, Santiago, Chile11-5020081
Costa Rica1-1020123
Jardim Paulista, Sao Paulo, Brazil11-5020211


Want to find more investors focusing on 欧博体育平台 endoscopy device industry?

If you want to find more investors that are active in 欧博体育平台 endoscopy deviceindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and 欧博体育平台re are a lot more private equity, venturecapital, and corporate investors like 欧博体育平台se globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and 欧博体育平台ir sizes.
  • Portfolio: Companies 欧博体育平台y've invested in.
  • Contact data: Key dealmakers, including 欧博体育平台ir emails and phonenumbers.
  • ...and much more!